Safety and tolerability of 'Ready-to-Use' (SOMAKIT TOC (R)) 68Ga-DOTA0-Tyr3-Octreotide (68Ga-DOTATOC) for injection in patients with proven gastro-entero-pancreatic neuroendocrine tumours (GEP-NETs).
Authors
Manoharan, PrakashNavalkissoor, S
Lamarca, Angela
Calero-Valdayo, Jose
Chan, P
Sierra, M
Caplin, M
Valle, Juan W
Affiliation
The Christie NHS Foundation Trust, ManchesterIssue Date
2017